MGMT and neoplasm: The following variables were involved; age ≥ 65 years, MGMT methylation status, FLAIR-T2 abnormality ≥ 60 cm3 or ≥ 2,000 mm3 and FLAIR-T2/tumor ratio ≥ 5 for all methods.